Stockreport

InMed Pharmaceuticals GAAP EPS of -$1.01, revenue of $4.6M [Seeking Alpha]

InMed Pharmaceuticals Inc. - Common Shares  (INM) 
PDF As of June 30, 2024, we had cash, cash equivalents and short-term investments of $6.6 million. The company expects its cash will be sufficient to fund its planned ope [Read more]